Sargin oral solution 200 mg/ml 100 ml

Sargin oral solution is used in the complex therapy of atherosclerosis of the vessels of the heart and brain, arterial hypertension, atherosclerosis of peripheral vessels; diabetic angiopathy; chronic heart failure; hypercholesterolemia; chronic obstructive pulmonary diseases, pulmonary hypertension; asthenic conditions.

Composition

Active ingredient: L-arginine aspartate.

1 ml of solution contains Arginine aspartate (L-arginine aspartate) - 200 mg.

Excipients: propyl parahydroxybenzoate (E 216), methyl parahydroxybenzoate (E 218), sorbitol (E 420), sodium saccharin (E 954), grape flavoring, purified water.

Contraindication

Hypersensitivity, severe renal dysfunction. Myocardial infarction (including history).

Method of application

Use orally, take with meals. Adults with atherosclerosis of the heart and brain vessels, atherosclerosis of peripheral vessels, diabetic angiopathy - 5 ml (1 measuring spoon - 1 g of the drug) 3-8 times a day. With hypercholesterolemia, arterial hypertension - 5 ml 3-6 times a day. With chronic obstructive pulmonary diseases, pulmonary hypertension - 5 ml 3-6 times a day. With asthenic conditions - 5 ml 4-8 times a day. The maximum daily dose is 8 g. The duration of the course of treatment is 8-15 days; if necessary, the course of treatment should be repeated.

Application features

It should be used with caution in cases of electrolyte imbalance and kidney disease. When using the drug, it is necessary to adhere to a balanced sleep and rest regimen, and to avoid alcohol, nicotine, and psychostimulants. If symptoms of asthenia increase while taking the drug, treatment should be discontinued.

Pregnant women

The drug penetrates the placenta, so it can be used during pregnancy only if the expected benefit to the mother outweighs the potential risk to the fetus.

There are no data on the use of the drug during breastfeeding.

Children

Do not use in patients under 18 years of age.

Drivers

No effect.

Overdose

Symptoms: hypersensitivity reactions, hypoglycemic states.

Treatment. If these symptoms occur, the drug should be discontinued. Gastric lavage and sorbents are indicated. There is no antidote. Symptomatic therapy.

Side effects

Musculoskeletal system: joint pain.

On the part of the digestive tract: rarely - a feeling of mild discomfort in the stomach and intestines, nausea immediately after taking the drug, which disappear on their own.

Immune system disorders: hypersensitivity reactions, including bronchospasm.

Laboratory indicators: hyperkalemia.

Interaction

When using arginine aspartate, it is necessary to take into account that the combined use of aminophylline with arginine may be accompanied by an increase in insulin levels in the blood, and spironolactone with arginine may be accompanied by an increase in potassium levels in the blood.

Arginine is incompatible with thiopental.

Storage conditions

The drug does not require special storage conditions.

Keep out of reach of children.

Shelf life - 2 years.